Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laughter and tapping: surprising Stress-Busters for expecting moms?

NCT ID NCT07449013

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two relaxation methods—laughter yoga and emotional freedom technique (EFT, a type of tapping)—to see if they could lower anxiety in pregnant women. 120 pregnant women with high anxiety scores took part. The goal was to find simple, drug-free ways to help moms-to-be feel calmer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Jan 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For the laughter yoga group: Pregnant women who are willing to participate in the study, can read and understand Turkish, are aged 18 or over, have scored 37 or above on the STAI, have a spontaneous pregnancy, are in their second or third trimester, and have not previously practised laughter yoga. * For the emotional freedom technique(EFT) group: Pregnant women who are willing to participate in the study, can read and understand Turkish, are aged 18 or over, have scored 37 or above on the STAI, have a spontaneous pregnancy, are in their second or third trimester, have not previously undergone EFT, and have no infections, wounds, scars, etc. in the tapping areas where EFT will be applied. * For the control group: Pregnant women who volunteered to participate in the study, can read and understand Turkish, are aged 18 or over, scored 37 or above on the STAI, have a spontaneous pregnancy, are in their second or third trimester, and have not previously practised laughter yoga or EFT. Exclusion Criteria: * For the laughter yoga group: Those wishing to continue working, those diagnosed with a high-risk pregnancy, those with chronic illnesses (hypertension, diabetes, thyroid disorders, etc.), those with psychiatric illnesses and/or undergoing psychiatric treatment (pharmacotherapy or psychotherapy), those with any issues that prevent communication (such as impaired hearing, speech, or comprehension), those using pharmacological or non-pharmacological methods to reduce anxiety, those who have undergone abdominal surgery in the last three months, and pregnant women with glaucoma, hernia, epilepsy, bleeding haemorrhoids, or heart disease. * For the EFT and control group: Those who do not wish to continue the study, those diagnosed with a high-risk pregnancy, those with chronic illnesses (hypertension, diabetes, thyroid disorders, etc.), Those with psychiatric disorders and/or undergoing psychiatric treatment (pharmacotherapy or psychotherapy), Those with any condition that impedes communication (such as impaired hearing, speech, or comprehension), Pregnant women using either pharmacological or non-pharmacological methods to reduce anxiety.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kırklareli Healthy Life Center

    Kırklareli, Centre, 39000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.